The European Medicines Agency (EMEA) recommended contraindicating Acomplia (rimonabant) from sanofi-aventis, in patients with ongoing major depression or who are being treated with antidepressants, because of the risk of psychiatric side effects. [click link for full article]
From: www.medicalnewstoday.com
European Medicines Agency Recommends Acomplia Must Not Be Used In Patients On Antidepressants Or With Major Depression
Posted by Ruslan Abuzant at 2:32 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment